Citigroup Inc Angion Biomedica Corp. Transaction History

Citigroup Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.94 - $1.23 $152 - $199	-162 Reduced 4.15%	3,743 $3,000
Q2 2022 Aug 10, 2022	SELL	$1.1 - $2.23 $4,457 - $9,035	-4,052 Reduced 50.92%	3,905 $4,000
Q1 2022 May 12, 2022	SELL	$1.72 - $2.96 $2,332 - $4,013	-1,356 Reduced 14.56%	7,957 $17,000
Q4 2021 Feb 10, 2022	BUY	$2.35 - $9.95 $16,052 - $67,968	6,831 Added 275.22%	9,313 $27,000
Q3 2021 Nov 10, 2021	BUY	$9.31 - $13.25 $23,107 - $32,886	2,482 New	2,482 $24,000

Ticker ANGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,113,300
Description
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.